Literature DB >> 8576107

Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein.

T Ohtsuka1, K Shimizu, B Yamamori, S Kuroda, Y Takai.   

Abstract

Rap1 small GTP-binding protein has the same amino acid sequence at its effector domain as that of Ras. Rap1 has been shown to antagonize the Ras functions, such as the Ras-induced transformation of NIH 3T3 cells and the Ras-induced activation of the c-Raf-1 protein kinase-dependent mitogen-activated protein (MAP) kinase cascade in Rat-1 cells, whereas we have shown that Rap1 as well as Ras stimulates DNA synthesis in Swiss 3T3 cells. We have established a cell-free assay system in which Ras activates bovine brain B-Raf protein kinase. Here we have used this assay system and examined the effect of Rap1 on the B-Raf activity to phosphorylate recombinant MAP kinase kinase (MEK). Recombinant Rap1B stimulated the activity of B-Raf, which was partially purified from bovine brain and immunoprecipitated by an anti-B-Raf antibody. The GTP-bound form was active, but the GDP-bound form was inactive. The fully post-translationally lipid-modified form was active, but the unmodified form was nearly inactive. The maximum B-Raf activity stimulated by Rap1B was nearly the same as that stimulated by Ki-Ras. Rap1B enhanced the Ki-Ras-stimulated B-Raf activity in an additive manner. These results indicate that not only Ras but also Rap1 is involved in the activation of the B-Raf-dependent MAP kinase cascade.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8576107     DOI: 10.1074/jbc.271.3.1258

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  The strength of interaction at the Raf cysteine-rich domain is a critical determinant of response of Raf to Ras family small GTPases.

Authors:  T Okada; C D Hu; T G Jin; K Kariya; Y Yamawaki-Kataoka; T Kataoka
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Retroviral inhibition of cAMP-dependent protein kinase inhibits myelination but not Schwann cell mitosis stimulated by interaction with neurons.

Authors:  D G Howe; K D McCarthy
Journal:  J Neurosci       Date:  2000-05-15       Impact factor: 6.167

Review 3.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

4.  Circadian regulation of cGMP-gated channels of vertebrate cone photoreceptors: role of cAMP and Ras.

Authors:  Gladys Y-P Ko; Michael L Ko; Stuart E Dryer
Journal:  J Neurosci       Date:  2004-02-11       Impact factor: 6.167

Review 5.  New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review.

Authors:  Yanju Bao; Yebo Gao; Liping Yang; Xiangying Kong; Honggang Zheng; Wei Hou; Baojin Hua
Journal:  Channels (Austin)       Date:  2015       Impact factor: 2.581

6.  Rapgef2 connects GPCR-mediated cAMP signals to ERK activation in neuronal and endocrine cells.

Authors:  Andrew C Emery; Maribeth V Eiden; Tomris Mustafa; Lee E Eiden
Journal:  Sci Signal       Date:  2013-06-25       Impact factor: 8.192

Review 7.  Small G protein signaling in neuronal plasticity and memory formation: the specific role of ras family proteins.

Authors:  Xiaojing Ye; Thomas J Carew
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

Review 8.  Ras and Rap1: A tale of two GTPases.

Authors:  Seema Shah; Ethan J Brock; Kyungmin Ji; Raymond R Mattingly
Journal:  Semin Cancer Biol       Date:  2018-04-03       Impact factor: 15.707

9.  Akt and ERK1/2 pathways are components of the vasopressin signaling network in rat native IMCD.

Authors:  Trairak Pisitkun; Vinitha Jacob; Stephen M Schleicher; Chung-Lin Chou; Ming-Jiun Yu; Mark A Knepper
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30

10.  Rap1 signaling prevents L-type calcium channel-dependent neurotransmitter release.

Authors:  Jaichandar Subramanian; Louis Dye; Alexei Morozov
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.